Literature DB >> 6324033

Effects of ethosuximide and tetramethylsuccinimide on cultured cortical neurons.

D M Barnes, M A Dichter.   

Abstract

In cultured cortical neurons, ethosuximide (ESM) had unexpected actions for an antiepileptic drug; it slightly diminished the effects of inhibitory neurotransmitters, GABA, and glycine. ESM had no direct membrane effects, did not change action potential characteristics or alter spontaneous activity, and did not reverse the effects of convulsants that are GABA antagonists. The structurally related convulsant tetramethylsuccinimide (TMSM) reduced the amplitude of GABA-mediated inhibitory postsynaptic potentials and antagonized responses to applied GABA, effects not reversed by ESM. The convulsant effects of TMSM include a blockade of postsynaptic GABA actions, but the antiepileptic effects of ESM are not due to an enhancement of GABA-mediated inhibition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324033     DOI: 10.1212/wnl.34.5.620

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: GABA current blockade.

Authors:  D A Coulter; J R Huguenard; D A Prince
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

2.  Effects of T-type, L-type, N-type, P-type, and Q-type calcium channel blockers on stimulus-induced pre- and postsynaptic calcium fluxes in rat hippocampal slices.

Authors:  P Igelmund; Y Q Zhao; U Heinemann
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

Review 3.  Anticonvulsant drug actions on neurons in cell culture.

Authors:  R L Macdonald
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction.

Authors:  D A Coulter; J R Huguenard; D A Prince
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.